FMR LLC reduced its holdings in China National Pharmaceutical Group Corporation (01099) by approximately 1.3961 million shares, at an average price of about HK$17.05 per share.

According to the latest data from the Hong Kong Stock Exchange, on July 29, FMR LLC reduced its holdings in China National Pharmaceutical Group Corporation (01099) by 1,396,075 shares, at a price of HKD 17.0474 per share, totaling approximately HKD 23,799,400. After the reduction, the latest number of shares held is approximately 79,493,000, with a current shareholding ratio of 5.92%.